Page 12 - TD-2-1

Tumor Discovery RAGEs in oral squamous cell carcinoma

Author contributions https://doi.org/10.1007/s00109-005-0688-7

Conceptualization: Palati Sinduja 8. Taguchi A, Blood DC, del Toro G, et al., 2000, Blockade of
RAGE-amphoterin signalling suppresses tumour growth
Formal analysis: Palati Sinduja, Pratibha Ramani and metastases. Nature, 405(6784): 354–360.
Writing – original draft: Palati Sinduja https://doi.org/10.1038/35012626
Writing – review & editing: Pratibha Ramani, Saravanan 9. Schmidt AM, Stern DM, 2001, Receptor for age (RAGE)
Sekaran is a gene within the major histocompatibility class III
region: Implications for host response mechanisms in
Ethics approval and consent to participate homeostasis and chronic disease. Front Biosci J Virtual Libr,
6(3): 1151–1160.
Not applicable.
https://doi.org/10.2741/schmidt
Consent for publication 10. Choi J, Lee MK, Oh KH, et al., 2011, Interaction effect
Not applicable. between the receptor for advanced glycation end products
(RAGE) and high-mobility group box-1 (HMGB-1) for the
Availability of data migration of a squamous cell carcinoma cell line. Tumori J,
97(2): 196–202.
Not applicable.
https://doi.org/10.1177/030089161109700211
References 11. Kierdorf K, Fritz G, 2013, RAGE regulation and signaling in
inflammation and beyond. J Leukoc Biol, 94(1): 55–68.
1. Scully C, Bagan J, 2009, Oral squamous cell carcinoma
overview. Oral Oncol, 45(4–5): 301–308. https://doi.org/10.1189/jlb.1012519
https://doi.org/10.1016/j.oraloncology.2009.01.004 12. Bergers G, Benjamin LE, 2003, Tumorigenesis and the
2. López-Graniel CM, de León DT, Meneses-García A, et al., angiogenic switch. Nat Rev Cancer, 3(6): 401–410.
2001, Tumor angiogenesis as a prognostic factor in oral https://doi.org/10.1038/nrc1093
cavity carcinomas. J Exp Clin Cancer Res, 20(4): 463–468.
13. Carmeliet P, 2005, VEGF as a key mediator of angiogenesis
3. Hofmann MA, Drury S, Fu C, et al., 1999, RAGE mediates a in cancer. Oncology, 69 Suppl 3: 4–10.
novel proinflammatory axis: A central cell surface receptor
for S100/calgranulin polypeptides. Cell, 97(7): 889–901. https://doi.org/10.1159/000088478
14. Shweiki D, Itin A, Soffer D, et al., 1992, Vascular endothelial
https://doi.org/10.1016/s0092-8674(00)80801-6
growth factor induced by hypoxia may mediate hypoxia-
4. Hori O, Brett J, Slattery T, et al., 1995, The receptor for initiated angiogenesis. Nature, 359(6398): 843–845.
advanced glycation end products (RAGE) is a cellular
binding site for amphoterin mediation of neurite outgrowth https://doi.org/10.1038/359843a0
and co-expression of rage and amphoterin in the developing 15. Ko SY, Ko HA, Shieh TM, et al., 2014, Cell migration is
nervous system. J Biol Chem, 270(43): 25752–25761. regulated by AGE-RAGE interaction in human oral cancer
cells in vitro. PLoS One, 9(10): e110542.
https://doi.org/10.1074/jbc.270.43.25752
https://doi.org/10.1371/journal.pone.0110542
5. Sugaya K, Fukagawa T, Matsumoto K, et al., 1994, Three
genes in the human MHC class III region near the junction 16. Sasahira T, Kirita T, Bhawal UK, et al., 2007, Receptor for
with the class II: Gene for receptor of advanced glycosylation advanced glycation end products (RAGE) is important in
end products, PBX2 homeobox gene and a notch homolog, the prediction of recurrence in human oral squamous cell
human counterpart of mouse mammary tumor gene int-3. carcinoma. Histopathology, 51(2): 166–172.
Genomics, 23(2): 408–419.
https://doi.org/10.1111/j.1365-2559.2007.02739.x
https://doi.org/10.1006/geno.1994.1517
17. Hutajulu SH, Paramita DK, Santoso J, et al., 2018, Correlation
6. Vissing H, Aagaard L, Tommerup N, et al., 1994, Localization between vascular endothelial growth factor-A expression
of the human gene for advanced glycosylation end product- and tumor location and invasion in patients with colorectal
specific receptor (AGER) to chromosome 6p21.3. Genomics, cancer. J Gastrointest Oncol, 9(6): 1099–1108.
24(3): 606–608.
https://doi.org/10.21037/jgo.2018.07.01
https://doi.org/10.1006/geno.1994.1676
18. Kukreja I, Kapoor P, Deshmukh R, et al., 2013, VEGF and
7. Bierhaus A, Humpert PM, Morcos M, et al., 2005, CD 34: A correlation between tumor angiogenesis and
Understanding RAGE, the receptor for advanced glycation microvessel density-an immunohistochemical study. J Oral
end products. J Mol Med (Berl), 83(11): 876–886. Maxillofac Pathol, 17(3): 367–373.

Volume 2 Issue 1 (2023) 6 https://doi.org/10.36922/td.244